A. Moran

PRP-1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β-catenin pathway in human chondrosarcoma JJ012 cells

Jeffrey Brown, J. Brown, K. Galoian, 2019, Oncology reports.

Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma

A. Galoyan, T. Davtyan, Albert S Lee, 2017, International journal of oncology.

PRP-1, a toll-like receptor ligand, upregulates the unfolded protein response in human chondrosarcoma cells.

Jeffrey Brown, K. Galoian, A. Hoyt, 2022, Cancer treatment and research communications.

Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide-1

Jeffrey Brown, S. Conway, K. Galoian, 2020, Molecular medicine reports.

Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta‐analysis

N. Merchant, D. Sleeman, D. Yakoub, 2019, Journal of surgical oncology.